FDA Approves Over-the-Counter Naloxone Spray for Opioid Overdose Treatment

The U.S. Food and Drug Administration has authorized a specific naloxone nasal spray for non-prescription sale. This decision aims to increase public access to a vital medication used for emergency opioid overdose reversal. Making it available in retail settings could significantly improve response times in overdose situations.